Evaluating the risk factors for liver injury in patients with chronic lymphocytic leukemia in the dynamics of chemotherapy
Journal Title: Гастроентерологія - Year 2019, Vol 53, Issue 2
Abstract
Background. B-cell chronic lymphocytic leukemia (B-CLL) treatment is accompanied by a risk of liver injury due to factors that depend on the characteristics of the patient, tumor, and chemotherapy (CT). The purpose was to assess the risk of development and nature of liver injury in patients with B-CLL in the dynamics of CT. Materials and methods. Seventy-six patients with В-CLL were examined, including 44 (57.9 %) men and 32 (42.1 %) women. The average age was (66.81 ± 12.50) years. The B-CLL stage was determined according to the Rai (1975, 1987) and Binet (1981, 2006) classifications. CT was administered in FC (fludarabine, cyclophosphamide) regimen. The patients were examined twice: before CT and after two FC courses. Hyperplastic syndrome and hyperleukocytosis were taken into account. Biochemical blood tests were evaluated. Common Terminology Criteria for Adverse Events, version 4.02, were used. Results. Advanced B-CLL stages (stage IV (C) according to Rai, Binet) are associated with an increased risk of no response on CT (risk ratio (RR) = 0.53; 95% confidence interval (CI) = 0.31–0.90; p < 0.05). The presence of hyperplastic syndrome is accompanied by a significant risk of no response on CT (RR = 0.23; 95% CI = 0.07–0.80; p < 0.05). Liver injury is more often detected in patients with B-CLL stages III (RR = 1.96; 95% CI = 1.33–2.88; p < 0.05) and IV (RR = 2.13; 95% CI = 1.47–3.08; p < 0.05) versus stage II by Rai. In patients with B-CLL, the risk of hepatotoxic reactions development is associated with low efficacy of CT, namely the achievement of partial response (RR = 3.18; 95% CI = 1.93–5.22; p < 0.05) and no response on CT (RR = 3.71; 95% СІ = 2.37–5.81; р < 0.05). Conclusions. The risk of liver injury increases in patients with B-CLL stage IV (C) and is associated with low CT efficacy.
Authors and Affiliations
G. S. Maslova, I. M. Skrypnyk
Keywords
Related Articles
- EP ID EP582154
- DOI 10.22141/2308-2097.53.2.2019.168986
- Views 70
- Downloads 0
Evaluating the Efficiency of Hepatoprotector Hepa Veda in Patients with Liver Pathology
The article presents the results of efficiency of monotherapy with hepatoprotector Hepa veda in patients with liver pathology. There were found a significant decrease of aminotransferase level in patients with non-alcoho...
Improving the Efficiency of Treatment of Patients with Overlap Syndrome Functional dyspepsia and Nonerosive Reflux Disease without the Presence of Helicobacter pylori
In overlap syndrome functional dyspepsia and non-erosive reflux disease (FD/NERD) it is important to evaluate and correct the motor function of the stomach, anxiety-depressive and dyspeptic manifestations which affect th...
Essential Phospholipids in the Treatment of Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) — a metabolic-related disease resulting from insulin resistance, which is characterized by fatty liver degeneration of varying degrees in the absence of other factors of liver inj...
Hemodynamic Changes in Patients with Chronic Pancreatitis on the Background of Coronary Heart Disease
The analysis of the survey results in 120 patients with chronic pancreatitis and coronary heart disease was conducted. Along with the standard examination, these patients underwent Doppler imaging of the abdominal aorta...
Enthusiast in County Medicine in the Yekaterinoslavschina-Dnipropetrovschina Region
There have been described life and professional activity of Petro Sochinskyi, a county physician in the Katerynoslavscyna, public activist, collector, folklorist, benefactor, acting member of Yekaterinoslavskaya Scientif...